Prescription drug · NDA
Ativan (Lorazepam) NDC 0641-6000
Lorazepam 2 mg/mL · Injection · Intramuscular, Intravenous · Hikma Pharmaceuticals USA Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0641-6000-10 | 0064160001000641600010 | 10 VIAL in 1 CARTON (0641-6000-10) / 10 mL in 1 VIAL (0641-6000-01)Marketed from Jul 25, 1980 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ativan
- Generic name (nonproprietary)
- lorazepam
- Active ingredients
- Lorazepam — 2 mg/mL
- Dosage form
- Injection
- Route
- Intramuscular, Intravenous
- Labeler
- Hikma Pharmaceuticals USA Inc.NDC labeler code 0641
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 018140
- Marketing start
- Listing expires
- DEA schedule
- CIV
- Other FDA classes
- Benzodiazepines (Chemical structure)
- Identifiers
- Product ID 0641-6000_fb40dcce-9da3-49b4-9bde-e01a17abeae6SPL ID fb40dcce-9da3-49b4-9bde-e01a17abeae6
- Pharmacologic class
- Benzodiazepine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400641600010followed by a unit qualifier and the quantityPackage 00641-6000-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 0641-6000
- What is NDC 0641-6000?
- 0641-6000 is the product NDC for Ativan (lorazepam), Lorazepam 2 mg/mL injection, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Ativan (Lorazepam).
- What is the active ingredient?
- Lorazepam.
- Who is the labeler?
- Hikma Pharmaceuticals USA Inc., NDC labeler code 0641. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Ativan?
- 6 other product NDCs are listed under this name. See all Ativan NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Ativan products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Ativanlorazepam | Lorazepam .5 mg/1 | TabletOral | Bausch Health US LLC | 0187-0063 | 00187-0063-01 |
| Ativanlorazepam | Lorazepam 1 mg/1 | TabletOral | Bausch Health US LLC | 0187-0064 | 00187-0064-01 |
| Ativanlorazepam | Lorazepam 2 mg/1 | TabletOral | Bausch Health US LLC | 0187-0065 | 00187-0065-01 |
| Ativanlorazepam | Lorazepam 2 mg/mL | InjectionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0641-6001 | 00641-6001-25 |
| Ativanlorazepam | Lorazepam 4 mg/mL | InjectionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0641-6002 | 00641-6002-10 |
| Ativanlorazepam | Lorazepam 4 mg/mL | InjectionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0641-6003 | 00641-6003-25 |
Other NDCs under NDA 018140
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Ativanlorazepam | Lorazepam 2 mg/mL | InjectionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0641-6001 |
| Ativanlorazepam | Lorazepam 4 mg/mL | InjectionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0641-6002 |
| Ativanlorazepam | Lorazepam 4 mg/mL | InjectionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0641-6003 |
| Lorazepam | Lorazepam 2 mg/mL | InjectionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0641-6044 |
| Lorazepam | Lorazepam 4 mg/mL | InjectionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0641-6045 |
| Lorazepam | Lorazepam 2 mg/mL | InjectionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0641-6046 |
| Lorazepam | Lorazepam 4 mg/mL | InjectionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0641-6047 |
| Lorazepam | Lorazepam 2 mg/mL | InjectionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0641-6048 |
| Lorazepam | Lorazepam 4 mg/mL | InjectionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0641-6049 |
| Lorazepam | Lorazepam 2 mg/mL | InjectionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0641-6050 |
| Lorazepam | Lorazepam 4 mg/mL | InjectionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0641-6051 |
| Lorazepam | Lorazepam 2 mg/mL | InjectionIntramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. | 0641-6207 |
| Lorazepam | Lorazepam 2 mg/mL | InjectionIntramuscular, Intravenous | Civica, Inc. | 72572-380 |